New advances in precision medicine for hepatocellular carcinoma recurrence prediction and treatment
Silvia Vilarinho, Diego F. Calvisi – 15 July 2014
Reciprocal activation between ATPase inhibitory factor 1 and NF‐κB drives hepatocellular carcinoma angiogenesis and metastasis
Ruipeng Song, Huiwen Song, Yingjian Liang, Dalong Yin, Heng Zhang, Tongsen Zheng, Jiabei Wang, Zhaoyang Lu, Xuan Song, Tiemin Pei, Youyou Qin, Yuejin Li, Changming Xie, Boshi Sun, Huawen Shi, Shuai Li, Xianzhi Meng, Guangchao Yang, Shangha Pan, Jiyuan Zhu, Shuyi Qi, Hongchi Jiang, Zhiyong Zhang, Lianxin Liu – 14 July 2014
Reply
Salvatore Petta, Giuseppe Cabibbo, Calogero Cammà – 14 July 2014
Effect of social support and donation‐related concerns on ambivalence of living liver donor candidates
Yun‐Chieh Lai, Wei‐Chen Lee, Yeong‐Yuh Juang, Lee‐Lan Yen, Li‐Chueh Weng, Hsueh Fen Chou – 13 July 2014 – Ambivalence in the decision‐making process for living liver donors has the potential to result in their experiencing a negative mental status. To promote donor candidates' well‐being, it is important to study the factors related to ambivalence. Thus, the aim of this study was to explore the ambivalence of living liver donor candidates and to investigate the effect of social support and donation‐related concerns on their ambivalence. A cross‐sectional design was used.
LI‐RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI‐RADS Management Working Group and future directions
Donald G. Mitchell, Jordi Bruix, Morris Sherman, Claude B. Sirlin – 12 July 2014 – To improve standardization and consensus regarding performance, interpreting, and reporting computed tomography (CT) and magnetic resonance imaging (MRI) examinations of the liver in patients at risk for hepatocellular carcinoma (HCC), LI‐RADS (Liver Imaging Reporting and Data System) was launched in March 2011 and adopted by many clinical practices throughout the world.
Phenotypic alterations of regulatory T cells in autoimmune hepatitis: Causal or associated with treatment and remission?
Marcial Sebode, Moritz Peiseler, Christina Weiler‐Normann, Christoph Schramm, Ansgar W. Lohse, Johannes Herkel – 12 July 2014
LI‐RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI‐RADS Management Working Group and future directions
Donald G. Mitchell, Jordi Bruix, Morris Sherman, Claude B. Sirlin – 12 July 2014 – To improve standardization and consensus regarding performance, interpreting, and reporting computed tomography (CT) and magnetic resonance imaging (MRI) examinations of the liver in patients at risk for hepatocellular carcinoma (HCC), LI‐RADS (Liver Imaging Reporting and Data System) was launched in March 2011 and adopted by many clinical practices throughout the world.
Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada
Brendan Jacka, Tanya Applegate, Mel Krajden, Andrea Olmstead, P. Richard Harrigan, Brandon D.L. Marshall, Kora DeBeck, M.‐J. Milloy, Francois Lamoury, Oliver G. Pybus, Viviane D. Lima, Gkikas Magiorkinis, Vincent Montoya, Julio Montaner, Jeffrey Joy, Conan Woods, Sabina Dobrer, Gregory J. Dore, Art F.Y. Poon, Jason Grebely – 12 July 2014
Cost‐effectiveness analysis of new drugs for chronic hepatitis C: The importance of updating utility values
Paolo A. Cortesi, Luciana Scalone, Lorenzo G. Mantovani – 12 July 2014